![](https://scx1.b-cdn.net/csz/news/tmb/2019/targetingold.jpg)
Targeting old bottleneck reveals new anticancer drug strategy
The enzyme ribonucleotide reductase is a bottleneck for cancer cell growth. Scientists at Winship Cancer Institute of Emory University have identified a way of targeting ribonucleotide reductase that may avoid the toxicity ...
Jul 22, 2019
0
53